A. Juan, C. Segrelles, Almudena Campo-Balguerías, Iván Bravo, Ignacio Silva, Jorge Peral, A. Ocaña, P. Clemente-Casares, C. Alonso-Moreno, C. Lorz
{"title":"抗-EGFR结合纳米颗粒提供Alpelisib作为头颈部癌症的靶向治疗","authors":"A. Juan, C. Segrelles, Almudena Campo-Balguerías, Iván Bravo, Ignacio Silva, Jorge Peral, A. Ocaña, P. Clemente-Casares, C. Alonso-Moreno, C. Lorz","doi":"10.1186/s12645-023-00180-z","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9408,"journal":{"name":"Cancer Nanotechnology","volume":" ","pages":"1-21"},"PeriodicalIF":4.5000,"publicationDate":"2023-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-EGFR conjugated nanoparticles to deliver Alpelisib as targeted therapy for head and neck cancer\",\"authors\":\"A. Juan, C. Segrelles, Almudena Campo-Balguerías, Iván Bravo, Ignacio Silva, Jorge Peral, A. Ocaña, P. Clemente-Casares, C. Alonso-Moreno, C. Lorz\",\"doi\":\"10.1186/s12645-023-00180-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9408,\"journal\":{\"name\":\"Cancer Nanotechnology\",\"volume\":\" \",\"pages\":\"1-21\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2023-03-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Nanotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1186/s12645-023-00180-z\",\"RegionNum\":2,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NANOSCIENCE & NANOTECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Nanotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1186/s12645-023-00180-z","RegionNum":2,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
Cancer NanotechnologyPharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
5.20
自引率
1.80%
发文量
37
审稿时长
15 weeks
期刊介绍:
Aim:
Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.
Scope:
Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.